Operating Lease, Payments in USD of BioCardia, Inc. from Q1 2019 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
BioCardia, Inc. quarterly/annual Operating Lease, Payments history and change rate from Q1 2019 to Q3 2025.
  • BioCardia, Inc. Operating Lease, Payments for the quarter ending 30 Sep 2025 was $125K, a 2.46% increase year-over-year.
  • BioCardia, Inc. Operating Lease, Payments for the twelve months ending 30 Sep 2025 was $375K, a 15% increase year-over-year.
  • BioCardia, Inc. annual Operating Lease, Payments for 2024 was $365K, a 15.9% increase from 2023.
  • BioCardia, Inc. annual Operating Lease, Payments for 2023 was $315K, a 32.9% increase from 2022.
  • BioCardia, Inc. annual Operating Lease, Payments for 2022 was $237K, a 65.5% decline from 2021.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Change (%)
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Change (%)

BioCardia, Inc. Quarterly Operating Lease, Payments (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2025 $375K $125K +$3K +2.46% 01 Jul 2025 30 Sep 2025 10-Q 12 Nov 2025
Q2 2025 $372K $124K +$3K +2.48% 01 Apr 2025 30 Jun 2025 10-Q/A 29 Oct 2025
Q1 2025 $369K $125K +$4K +3.31% 01 Jan 2025 31 Mar 2025 10-Q 14 May 2025
Q4 2024 $365K $1K +$39K 01 Oct 2024 31 Dec 2024 10-K 26 Mar 2025
Q3 2024 $326K $122K +$5K +4.27% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2025
Q2 2024 $321K $121K +$3K +2.54% 01 Apr 2024 30 Jun 2024 10-Q/A 29 Oct 2025
Q1 2024 $318K $121K +$3K +2.54% 01 Jan 2024 31 Mar 2024 10-Q 14 May 2025
Q4 2023 $315K -$38K +$12K +24% 01 Oct 2023 31 Dec 2023 10-K 26 Mar 2025
Q3 2023 $303K $117K +$3K +2.63% 01 Jul 2023 30 Sep 2023 10-Q 13 Nov 2024
Q2 2023 $300K $118K +$42K +55.3% 01 Apr 2023 30 Jun 2023 10-Q 13 Aug 2024
Q1 2023 $258K $118K +$21K +21.6% 01 Jan 2023 31 Mar 2023 10-Q 14 May 2024
Q4 2022 $237K -$50K +$74K +59.7% 01 Oct 2022 31 Dec 2022 10-K 27 Mar 2024
Q3 2022 $163K $114K -$48K -29.6% 01 Jul 2022 30 Sep 2022 10-Q 08 Nov 2023
Q2 2022 $211K $76K -$86K -53.1% 01 Apr 2022 30 Jun 2022 10-Q 09 Aug 2023
Q1 2022 $297K $97K -$389K -80% 01 Jan 2022 31 Mar 2022 10-Q 10 May 2023
Q4 2021 $686K -$124K -$280K -179% 01 Oct 2021 31 Dec 2021 10-K 29 Mar 2023
Q3 2021 $966K $162K +$4K +2.53% 01 Jul 2021 30 Sep 2021 10-Q 10 Nov 2021
Q2 2021 $962K $162K +$4K +2.53% 01 Apr 2021 30 Jun 2021 10-Q 10 Aug 2022
Q1 2021 $958K $486K +$328K +208% 01 Jan 2021 31 Mar 2021 10-Q 09 Nov 2022
Q4 2020 $630K $156K +$3K +1.96% 01 Oct 2020 31 Dec 2020 10-K 29 Mar 2022
Q3 2020 $627K $158K +$5K +3.27% 01 Jul 2020 30 Sep 2020 10-Q 10 Nov 2021
Q2 2020 $622K $158K +$5K +3.27% 01 Apr 2020 30 Jun 2020 10-Q 12 Aug 2021
Q1 2020 $617K $158K +$5K +3.27% 01 Jan 2020 31 Mar 2020 10-Q 13 May 2021
Q4 2019 $612K $153K 01 Oct 2019 31 Dec 2019 10-K 30 Mar 2021
Q3 2019 $153K 01 Jul 2019 30 Sep 2019 10-Q 10 Nov 2020
Q2 2019 $153K 01 Apr 2019 30 Jun 2019 10-Q 13 Aug 2020
Q1 2019 $153K 01 Jan 2019 31 Mar 2019 10-Q 15 May 2020

BioCardia, Inc. Annual Operating Lease, Payments (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 $365K +$50K +15.9% 01 Jan 2024 31 Dec 2024 10-K 26 Mar 2025
2023 $315K +$78K +32.9% 01 Jan 2023 31 Dec 2023 10-K 26 Mar 2025
2022 $237K -$449K -65.5% 01 Jan 2022 31 Dec 2022 10-K 27 Mar 2024
2021 $686K +$56K +8.89% 01 Jan 2021 31 Dec 2021 10-K 29 Mar 2023
2020 $630K +$18K +2.94% 01 Jan 2020 31 Dec 2020 10-K 29 Mar 2022
2019 $612K 01 Jan 2019 31 Dec 2019 10-K 30 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.